GUARDION HEALTH SCIENCES INC (GHSI)
US40145Q5009 - Common Stock
We assign a fundamental rating of 5 out of 10 to GHSI. GHSI was compared to 36 industry peers in the Personal Care Products industry. While GHSI has a great health rating, there are worries on its profitability. While showing a medium growth rate, GHSI is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
GHSI had positive earnings in the past year.
GHSI had a negative operating cash flow in the past year.
In the past 5 years GHSI reported 4 times negative net income.
GHSI had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of GHSI (41.65%) is better than 100.00% of its industry peers.
GHSI has a Return On Equity of 46.34%. This is amongst the best in the industry. GHSI outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 41.65% | ||
| ROE | 46.34% | ||
| ROIC | N/A |
ROA(3y)-59.1%
ROA(5y)-69.74%
ROE(3y)-76.49%
ROE(5y)-84.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
GHSI's Profit Margin of 99.10% is amongst the best of the industry. GHSI outperforms 100.00% of its industry peers.
The Gross Margin of GHSI (44.84%) is comparable to the rest of the industry.
GHSI's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 99.1% | ||
| GM | 44.84% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.13%
GM growth 5Y-5.18%
2. Health
2.1 Basic Checks
GHSI does not have a ROIC to compare to the WACC, probably because it is not profitable.
GHSI has more shares outstanding than it did 1 year ago.
GHSI has more shares outstanding than it did 5 years ago.
GHSI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
Based on the Altman-Z score of -5.72, we must say that GHSI is in the distress zone and has some risk of bankruptcy.
GHSI's Altman-Z score of -5.72 is on the low side compared to the rest of the industry. GHSI is outperformed by 94.44% of its industry peers.
There is no outstanding debt for GHSI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -5.72 |
ROIC/WACCN/A
WACC8.73%
2.3 Liquidity
GHSI has a Current Ratio of 16.67. This indicates that GHSI is financially healthy and has no problem in meeting its short term obligations.
GHSI's Current ratio of 16.67 is amongst the best of the industry. GHSI outperforms 100.00% of its industry peers.
GHSI has a Quick Ratio of 16.59. This indicates that GHSI is financially healthy and has no problem in meeting its short term obligations.
GHSI's Quick ratio of 16.59 is amongst the best of the industry. GHSI outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 16.67 | ||
| Quick Ratio | 16.59 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 154.16% over the past year.
The Revenue for GHSI has decreased by -43.45% in the past year. This is quite bad
The Revenue has been growing by 67.11% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)154.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%963.44%
Revenue 1Y (TTM)-43.45%
Revenue growth 3Y86.44%
Revenue growth 5Y67.11%
Sales Q2Q%-97.39%
3.2 Future
Based on estimates for the next years, GHSI will show a very negative growth in Earnings Per Share. The EPS will decrease by -110.23% on average per year.
GHSI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.78% yearly.
EPS Next Y-669.3%
EPS Next 2Y-110.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.56%
Revenue Next 2Y9.78%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 7.56, which indicates a rather cheap valuation of GHSI.
Based on the Price/Earnings ratio, GHSI is valued cheaper than 91.67% of the companies in the same industry.
When comparing the Price/Earnings ratio of GHSI to the average of the S&P500 Index (27.73), we can say GHSI is valued rather cheaply.
GHSI is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.56 | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
GHSI's earnings are expected to decrease with -110.23% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-110.23%
EPS Next 3YN/A
5. Dividend
5.1 Amount
GHSI has a Yearly Dividend Yield of 153.85%, which is a nice return.
In the last 3 months the price of GHSI has falen by -67.14%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 5.31, GHSI pays a better dividend. On top of this GHSI pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, GHSI pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 153.85% |
5.2 History
GHSI does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y-110.23%
EPS Next 3YN/A
GUARDION HEALTH SCIENCES INC
NASDAQ:GHSI (10/11/2024, 8:01:54 PM)
After market: 3.23 -0.02 (-0.62%)3.25
-0.01 (-0.31%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners7%
Inst Owner Change40.56%
Ins Owners206.25%
Ins Owner Change-3.79%
Market Cap4.39M
Analysts82.86
Price Target40.8 (1155.38%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 153.85% |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-51.78%
Min Revenue beat(2)-97.77%
Max Revenue beat(2)-5.79%
Revenue beat(4)1
Avg Revenue beat(4)-25.02%
Min Revenue beat(4)-97.77%
Max Revenue beat(4)6.34%
Revenue beat(8)2
Avg Revenue beat(8)-14.67%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.56 | ||
| Fwd PE | N/A | ||
| P/S | 0.68 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.32 | ||
| P/tB | 0.32 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.43
EY13.23%
EPS(NY)-1.04
Fwd EYN/A
FCF(TTM)-2.9
FCFYN/A
OCF(TTM)-2.9
OCFYN/A
SpS4.76
BVpS10.19
TBVpS10.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 41.65% | ||
| ROE | 46.34% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 99.1% | ||
| GM | 44.84% | ||
| FCFM | N/A |
ROA(3y)-59.1%
ROA(5y)-69.74%
ROE(3y)-76.49%
ROE(5y)-84.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.13%
GM growth 5Y-5.18%
F-Score6
Asset Turnover0.42
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 16.67 | ||
| Quick Ratio | 16.59 | ||
| Altman-Z | -5.72 |
F-Score6
WACC8.73%
ROIC/WACCN/A
Cap/Depr(3y)9.76%
Cap/Depr(5y)24.37%
Cap/Sales(3y)0.36%
Cap/Sales(5y)4.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)154.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%963.44%
EPS Next Y-669.3%
EPS Next 2Y-110.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-43.45%
Revenue growth 3Y86.44%
Revenue growth 5Y67.11%
Sales Q2Q%-97.39%
Revenue Next Year9.56%
Revenue Next 2Y9.78%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.97%
OCF growth 3YN/A
OCF growth 5YN/A